We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Synpromics Raises £5.2m of New Investment

News   Apr 20, 2017 | Original story from Synpromics

 
Synpromics Raises £5.2m of New Investment
 
 
 

RELATED ARTICLES

Fighting the Good Fight

News

Blocking an important enzyme in staphylococcal metabolism in a targeted manner would allow the pathogens to be starved.

READ MORE

Inflammation-blocking Inhibitor Could Treat Sepsis Too

News

A new inhibitor which decreases lung inflammation could hold the key to treating Acute Respiratory Distress Syndrome and sepsis.

READ MORE

Gene Editing Dramatically Improves Inherited Kidney Disease in Mice

News

Gene editing could be used to stop kidney damage in patients who have Joubert syndrome, an inherited kidney disease.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE